FLOW CYTOMETRY, CD 15

The Flow Cytometry CD15 Test is a specialized immunophenotyping assay used to evaluate the expression of CD15, a cell surface antigen commonly found on granulocytes, mature myeloid cells, and certain other cell populations. CD15 plays an important role in cell adhesion, migration, and immune responses and is widely used in hematology laboratories for the classification of blood and bone marrow disorders.

Flow cytometry enables rapid analysis of thousands of cells individually, allowing precise identification of CD15-positive cell populations and assessment of their immunophenotypic characteristics. The test is commonly performed as part of a comprehensive flow cytometry panel used in the diagnosis and classification of acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, and other hematological disorders.

CD15 expression is particularly useful in evaluating myeloid maturation patterns and identifying abnormalities within granulocytic cell populations. The marker may also contribute valuable information during the assessment of certain lymphoid malignancies and bone marrow disorders.

Benefits of the Test

• Evaluates granulocyte and myeloid cell populations
• Assists in leukemia diagnosis and classification
• Supports assessment of myeloid maturation
• Helps identify abnormal hematopoietic cell populations
• Contributes to bone marrow disorder evaluation
• Provides valuable immunophenotypic information

Why Doctors Recommend This Test

Doctors may recommend Flow Cytometry CD15 testing for:

• Suspected acute leukemia
• Myeloid leukemia evaluation
• Myelodysplastic syndrome investigation
• Bone marrow disorder assessment
• Abnormal blood counts
• Monitoring hematological malignancies
• Comprehensive leukemia immunophenotyping
• Evaluation of myeloid cell abnormalities

The test helps characterize abnormal cell populations and supports accurate disease classification.

Preparation Before Test

The test may require:

• Peripheral blood sample
• Bone marrow aspirate
• Other clinically appropriate specimens

Preparation generally includes:

• No fasting is required
• Inform your physician about current treatments
• Follow laboratory collection instructions

The procedure involves routine specimen collection followed by specialized flow cytometric analysis.

Normal Reporting Time

Results are generally available within 1 to 3 working days, depending on the complexity of the testing panel and laboratory workflow.

Who Should Take This Test?

• Patients with suspected leukemia
• Individuals with abnormal blood counts
• Patients undergoing bone marrow evaluation
• Individuals with suspected myeloid disorders
• Patients requiring immunophenotyping studies
• Individuals referred by hematologists or oncologists

Flow Cytometry CD15 testing is an important component of advanced hematology diagnostics and contributes to accurate classification of blood and bone marrow disorders.

Clinical Significance

CD15 expression may be observed in:

• Normal Granulocytes
• Acute Myeloid Leukemia (AML)
• Myelodysplastic Syndromes (MDS)
• Myeloproliferative Neoplasms (MPNs)
• Chronic Myeloid Leukemia (CML)
• Myeloid Maturation Disorders
• Certain Lymphoid Malignancies

Abnormal expression patterns may indicate disturbances in myeloid differentiation and help distinguish between different hematological conditions.

Important Note

CD15 is generally interpreted together with additional markers such as CD13, CD33, CD34, CD45, CD14, CD64, CD117, HLA-DR, and MPO (Myeloperoxidase). Comprehensive interpretation by a hematopathologist is necessary for accurate diagnosis and clinical management.